4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsEar Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorderRecruitingPhase 32026-09-28NCT05156398
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care SystemChemically-Induced Disorders, Drug-Related Side Effects and Adverse ReactionsRecruitingNot stated2026-05-01NCT04249375
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in ChildrenChemically-Induced Disorders, Drug-Related Side Effects and Adverse ReactionsRecruitingNot stated2026-05-01NCT00414115
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 12025-12-15NCT03330691